CME beat estimates and defended its moat, but the stock's muted response shows investors are still pricing the perpetual futures question.
By FinancialMarkets.com · July 22, 2026
CME Group entered this earnings report under a cloud. Investors spent the spring marking the stock down on fears that perpetual futures, 24/7 retail venues, and a friendlier regulator would chip away at the franchise. The second quarter offered a partial answer. The near-term panic looks overdone. The longer-term threat remains unresolved, and the stock's muted reaction shows investors know the difference.
A Beat That Steadied the Stock Instead of Lifting It
CME reported adjusted earnings of $2.99 a share against a FactSet consensus of $2.91. Revenue of $1.71 billion topped the $1.68 to $1.70 billion analysts expected. Both lines cleared the bar. The stock rose only about 1.4%.
That muted move carries the real message. A clean beat merely steadied a stock that had fallen about 19% since May, when regulators cleared crypto perpetual futures at Kalshi. CME now trades near 20 times earnings, close to a five-year low. Investors have moved past this quarter's numbers and are pricing a five-year competitive question.
Where the Growth Actually Came From
Look under the headline and the quarter softens. Total revenue rose just 1%. Clearing and transaction fees, the core business, fell to $1.35 billion from $1.39 billion, a drop of about 3%.
Market data carried the quarter. That line rose 20% to a record $238 million. Without it, total revenue would have fallen. About $7 million of the gain came from one-time audit and catch-up payments that management called non-recurring. Even the star line had some help.
Profit tells the same story. Adjusted operating income slipped to $1.19 billion from $1.20 billion. Adjusted operating margin fell to 69.5% from about 71%. Costs rose 6%, led by technology and licensing.
So how did earnings per share still rise? Mostly through items below the operating line. A lower tax rate helped, including one-time state tax benefits. The March conversion of preferred stock into common shares also lifted the per-share result. Investment income actually declined. The 1% growth in earnings per share reflects mix and tax rather than operating muscle.
The rate per contract offers one bright spot. It rose to $0.678, up about 2.6 cents from the first quarter, on a richer product and customer mix. That cushioned the volume decline without stopping the slide in transaction fees.
Why the Near-Term Bear Case Weakened
The quarter did rebut the harshest fear. Perpetual futures show no sign of draining CME's institutional volume. Open interest ended the quarter up 8% from a year ago and up 16% since January. July volume ran 18% ahead of last year. Large-holder positions set records in rates, equity indexes, and foreign exchange.
CME's own crypto business kept growing too. Crypto futures volume is up more than sevenfold in three years, a stretch when offshore perpetuals already existed. Management put hard numbers on the gap. CME clears $9 to $10 billion of daily crypto open interest. The new Kalshi bitcoin perpetual sat near $10 million.
The logic is simple. Institutions want price certainty, fixed settlement, and deep clearing. Perpetual futures track a leveraged spot price and reset through funding payments. They suit a retail trader chasing leverage far better than a risk manager hedging a real book. Through the first half, institutions supplied 94% of CME's volume. The firm also saved clients more than $95 billion in daily margin, a capital efficiency that a single rival contract would struggle to match.
Keefe, Bruyette and Woods made the bull case plainly. The firm upgraded CME in June and called the perpetual fear overblown given the company's low retail exposure. This quarter supports that view.
Why the Long-Term Question Stays Open
The bears worry about the path, not the print. Perpetual products are simple and trade all day. They can pull in retail users first, then build data, distribution, and liquidity over time. That is how a side market becomes a real one. CME's own defense, that retail venues could act as a free feeder system for its products, quietly admits these venues matter.
Regulation cuts both ways here. A strict clearing regime protects CME, but it can also slow the company down. The contrast this month was sharp. CME launched 24/7 gold trading while the CFTC stayed its 24/7 crude oil contract the day before launch. Newer venues, meanwhile, self-certify products with less friction. CME is fighting that gap in court, arguing perpetuals are swaps rather than futures. That case remains unresolved.
Volume trends add caution. UBS analyst Alex Kramm noted futures volume came in about 2% below expectations, blaming softer rates and energy activity, and he trimmed his pricing forecast. The core engine is running a bit slower than hoped.
CME's answer is a full product pipeline. Single-stock futures launch July 27 across more than 50 names, with more than 35 retail brokers ready for day one. TreasuryLink arrives in the fourth quarter to connect Treasury futures with cash Treasury markets. Compute futures, tied to AI chip rental costs, come later this year. Prediction markets are early but growing, with more than 140,000 accounts trading last quarter. The strategy is sound. Almost none of it is proven yet.
The Burden of Proof
The tone of the call matters as much as the numbers. Management came out swinging and spent most of the session defending its model rather than selling the beat. Terry Duffy said the first half was the strongest in company history, yet he devoted far more time to perpetuals than to record data revenue. That is a company playing defense on the story, even while the numbers hold.
CME returned about $1.2 billion to shareholders this quarter and bought back stock into the selloff. Its moat is real. Deep liquidity, clearing certainty, and capital savings are hard to copy. At a five-year-low multiple, the near-term threat does look overpriced.
Still, the quarter reframed the debate rather than settling it. The live question now is whether new venues can slowly build a parallel market, and whether the very meaning of a futures contract is about to shift. CME must show that innovation and regulation stay on its side as retail trading grows. The numbers bought time. The case stays open.